Skip to main content

Table 2 Clearance of Neisseria gonorrhoeae and Chlamydia trachomatis at all infected sites at 8th day

From: Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection

Infected sites

Doxycycline + ceftriaxone (n = 61)

Doxycycline + cefixime (n = 64)

ORs (95% CI)

p value

n

% (95% CI)

n

% (95% CI)

Subjects eradicated CT

 Genital

36

100.0

41

100.0

 

1

 Pharyngeal

12

100.0

4

57.1

 

0.036

 Rectal

4

100.0

6

100.0

 

1

  Genital + pharyngeal

6

75.0

4

66.7

1.46 (0.1–28.6)

1

 Rectal + pharyngeal

0

 

1

25.0

 

1

 All sites

58

95.1 (86.5–98.3)

56

87.5 (77.2–93.5)

2.7 (0.6–16.8)

0.21

Subjects eradicated NG

 Genital

36

100.0

41

100.0

 

1

 Pharyngeal

12

100.0

6

85.7

 

0.37

 Rectal

4

100.0

6

100.0

 

1

 Genital + pharyngeal

6

75

5

83.3

0.6 (0.1–15.5)

1

 Rectal + pharyngeal

1

100.0

3

75.0

 

1

 All sites

59

96.7 (88.8–99.1)

61

95.3 (87.1–98.4)

1.45 (0.16–17.89)

1

Subjects eradicated CT and NG

 Genital

36

100.0

41

100.0

 

1

 Pharyngeal

12

100.0

3

42.9

 

0.009

 Rectal

4

100.0

5

83.3

 

1

 Genital + pharyngeal

6

75.0

2

33.3

5.2 (0.4–108.1)

0.28

 Rectal + pharyngeal

0

0.0

1

25.0

 

1

 All sites

58

95.1 (86.5–98.3)

52

81.2 (70.0–88.9)

4.41 (1.11–25.7)

0.026

  1. CT Chlamydia trachomatis; NG Neisseria gonorrhoeae